Psychiatric outcomes 10 years after treatment with antidepressants or anxiolytics

被引:7
|
作者
Colman, Ian [1 ]
Croudace, Tim J. [2 ]
Wadsworth, Michael E. J. [3 ]
Kuh, Diana [3 ]
Jones, Peter B. [2 ]
机构
[1] Univ Alberta, Sch Publ Hlth, Dept Publ Hlth Sci, Edmonton, AB T6G 2G3, Canada
[2] Univ Cambridge, Dept Psychiat, Cambridge, England
[3] UCL, Sch Med, MRC Natl Survey Hlth & Dev, Dept Epidemiol & Publ Hlth, London W1N 8AA, England
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
D O I
10.1192/bjp.bp.107.043430
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Antidepressants and anxiolytics have demonstrated short-term efficacy, however, little is known about the long-term effectiveness of these drugs. Aims To investigate long-term psychiatric outcomes following antidepressant and/or anxiolytic use during an episode of mental disorder in mid-life. Method Members of the 1946 British birth cohort were assessed for symptoms of depression and anxiety at age 43. Among 157 with mental disorder, those using antidepressants and/or anxiolytics were compared with those not using medications on psychiatric outcomes at age 53. Results Use of antidepressants or anxiolytics was associated with a lower prevalence of mental disorder at age 53 (odds ratio (OR)=0.3, 95% Cl 0.1-1.0) after adjustment for eight variables in a propensity-for-treatment analysis. Only 24% of those being treated with medications at age 43 were still using them at 53. Conclusions Use of antidepressants or anxiolytics during an episode of mental disorder may have long-term beneficial effects on mental health. This may be because of a demonstrated willingness to seek help rather than long-term maintenance therapy.
引用
收藏
页码:327 / 331
页数:5
相关论文
共 50 条
  • [31] Continued efficacy of cerezyme after 10 years of treatment
    Weinreb, Neal
    Balwani, Manisha
    Charrow, Joel
    Cole, Alexander
    Tripuraneni, Radhika
    Villalobos, Jacobo
    Kerstenetzky, Marcelo
    Hollak, Carla
    MOLECULAR GENETICS AND METABOLISM, 2011, 102 (02) : S45 - S45
  • [32] Botolinum toxin in headache treatment: 10 years after
    Relja, M.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (07) : CXI - CXI
  • [33] SQUAMOUS CELL EPITHELIOMA - 10 YEARS AFTER TREATMENT
    CANNON, AB
    AMA ARCHIVES OF DERMATOLOGY AND SYPHILOLOGY, 1950, 62 (06): : 912 - 912
  • [34] CANCER OF RECTUM 10 TO 20 YEARS AFTER TREATMENT
    QUAN, SHQ
    DISEASES OF THE COLON & RECTUM, 1970, 13 (01) : 26 - +
  • [35] ADHERENCE TO BISPHOSPHONATES: OUTCOMES AFTER SIX YEARS OF TREATMENT
    Pastore, Renato
    Daniela, Mentuccia
    Frajese, G. Vanni
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S187 - S187
  • [36] 10 YEARS AFTER, 10 YEARS HENCE
    HITCH, CJ
    DAEDALUS, 1975, (WIN) : 56 - 60
  • [37] Pregnancy outcomes after prenatal exposure to antidepressants
    Borgida, Adam F.
    Feldman, Deborah M.
    Ricci, Stephanie
    Ingardia, Charles J.
    OBSTETRICS AND GYNECOLOGY, 2006, 107 (04): : 60S - 61S
  • [38] Biomarkers and clinical outcomes after cessation of tezepelumab after 2 years of treatment (DESTINATION)Biomarkers and clinical outcomes after cessation of tezepelumab after 2 years of treatment (DESTINATION)
    Brightling, Christopher E.
    Jackson, David
    Kotalik, Ales
    Molfino, Nestor A.
    Caveney, Scott
    Colice, Gene
    Martin, Neil
    Israel, Elliot
    Pavord, Ian D.
    Wechsler, Michael E.
    Porsbjerg, Celeste
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [40] The Weber Conundrum: Outcomes of Conservative versus Surgical Treatment of Weber B Ankle Fracture after 10 years
    Makarem, Nader
    Tannast, Moritz
    SWISS MEDICAL WEEKLY, 2022, 152 : 22S - 22S